Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results

By Pridohl O.   Heinemann K.   Hartwig T.   Witzigmann H.   Lamesch P.   Fangmann J.   Berr F.   Hauss J.   Kohlhaw K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3229-3231

Elsevier

Access to resources Recommend Favorite

Immunosuppression in Auxiliary Partial Liver Transplantation With FK506 in Rats

By Hossain M.A.   Hamamoto I.   Kobayashi S.   Maeba T.   Maeta H.  

Transplantation Proceedings, Vol. 29, Iss. 8, 1997-12 ,pp. : 3617-3618

Elsevier

Access to resources Recommend Favorite

Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong

By Lo C.M.   Fan S.T.   Liu C.L.   Chan K.L.   NG I.O.L.   Lai C.L.   Lau G.K.K.   Fung S.K.Y.   Wong J.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3587-3588

Elsevier

Access to resources Recommend Favorite

Frequency of switch from cyclosporine to fk 506 before and after neoral use in pediatric liver transplantation

By Gridelli B.   Colledan M.   Lucianetti A.   Ulla L.   Riva S.   Segalin A.   Fassati L.R.   Torre G.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1861-1862

Elsevier

Access to resources Recommend Favorite

Improved Immunosuppression With Combination Tacrolimus (FK506) and Mycophenolic Acid in Orthotopic Liver Transplantation

By Cai T.H.   Esterl R.M.   Nichols L.   Cigarroa F.   Speeg K.V.   Halff G.A.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1413-1414

Elsevier

Access to resources Recommend Favorite